Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.

Move comes 2 years after controversial exit of brand-name product ...

The Hailie Smartinhaler, from med-tech company Adherium, improves asthma control by ensuring inhalers are used effectively and at the right time. It has been assisting American asthmatics since 2017; ...

A new asthma treatment, depemokimab, has shown promise in reducing exacerbations while maintaining a strong safety profile, according to findings presented at the 2025 American Academy of Allergy, ...

Initiation of GLP-1 receptor agonists was linked to fewer asthma exacerbations across overweight, obese, and morbidly obese patient cohorts.

Add Yahoo as a preferred source to see more of our stories on Google. A new study shows that a dual-action inhaler cuts asthma attacks in children almost in half. (CREDIT: Imperial College London) For ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Please provide your email address to receive an email when new articles are posted on . Data came from the FDA Adverse Event Reporting System from 2004 to 2024. Omalizumab had significant associations ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 AAAAI Annual Meeting.

The change will make asthma infusion treatments a pharmacy benefit, meaning policyholders will have to self-inject these four asthma infusion medications. Mykal McEldowney/IndyStar USA TODAY NETWORK A ...